Keryx Biopharma (KERX) Slumps Following Dilutive Stock Offering
Tweet Send to a FriendGet Alerts KERX Hot Sheet
Up)
Trade KERX Now!
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) shares are dipping in after-hours trading Tuesday after announcing that it commenced a $55 million common stock offering.
Striking while the iron is hot, Keryx shares are up 143 percent since the close last Friday on stronger Zernex results.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Striking while the iron is hot, Keryx shares are up 143 percent since the close last Friday on stronger Zernex results.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- 50-Day SMA Crossers 05/20: (ELN) (ACI) (AAPL) Above; (MRK) (TLAB) (CLSN) Below
- Short Sellers See the Light (HLF) (FSLR) (NFLX) (TLSA)
Create E-mail Alert Related Categories
Equity Offerings, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
